SCHEMBL2769262

SCHEMBL2769262

CCOC(=O)CC(C)N(S)C(=O)Nc1noc2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.43
TP53 P04637 7/20 0.43
MAPT P10636 2/20 0.43
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
KCNJ6 P48051 1/20 0.39
KCNJ3 P48549 1/20 0.39
FAAH O00519 6/20 0.38
EPHX2 P34913 1/20 0.38
KDM4E B2RXH2 3/20 0.37
LMNA P02545 2/20 0.37
HPGD P15428 2/20 0.37
HSD17B10 Q99714 2/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2770485 0.86 SMN1; SMN2 (0.46) SMN1; SMN2TP53MAPTALOX15TSHR
SCHEMBL2768531 0.83 NLRP3 (0.31) TSHRLMNA
SCHEMBL2769259 0.78 TP53 (0.44) SMN1; SMN2TP53MAPTALOX15TSHR
SCHEMBL14721153 0.77 SMN1; SMN2 (0.52) SMN1; SMN2TP53MAPTALOX15TSHR
SCHEMBL2768736 0.75 SMN1; SMN2 (0.48) SMN1; SMN2TP53MAPTTSHRKDM4E
SCHEMBL2769868 0.72 SMN1; SMN2 (0.46) SMN1; SMN2TP53MAPTALOX15TSHR
SCHEMBL2442471 0.70 SMN1; SMN2 (0.52) SMN1; SMN2TP53MAPTALOX15TSHR
SCHEMBL2771154 0.69 TP53 (0.48) SMN1; SMN2TP53MAPTALOX15TSHR
SCHEMBL7089986 0.68 SMN1; SMN2 (0.63) SMN1; SMN2TP53MAPTALOX15TSHR
Cyclohexane SCHEMBL2446980 0.67 TP53 (0.58) SMN1; SMN2TP53MAPTALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881967-B1 SUBSTITUTED BENZO(D)ISOXAZOL-3-YL AMINE COMPOUNDS AS ANALGESICS GRUENENTHAL GMBH (DE) 2010-04-28 EP claimed
US-20080176915-A1 Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics GRUENENTHAL GMBH (DE) 2008-07-24 US claimed
US-7696238-B2 Substituted benzo[d]isoxazol-3-yl amine compounds as analgesics GRUENENTHAL GMBH (DE) 2010-04-13 US disclosed
US-20080176915-A1 Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics GRUENENTHAL GMBH (DE) 2008-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176915-A1 Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics KCNQ1, KCNQ2, KCNQ3 SMN1; SMN2 1349/4885TP53 4784/4885MAPT 2492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.